Lithium: Stabilizing Mood with Precision Neurochemical Action
| Product dosage: 300mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 90 | $0.48 | $43.00 (0%) | 🛒 Add to cart |
| 180 | $0.39 | $86.00 $69.66 (19%) | 🛒 Add to cart |
| 270 | $0.35 | $129.00 $94.60 (27%) | 🛒 Add to cart |
| 360 | $0.33
Best per pill | $172.00 $119.54 (31%) | 🛒 Add to cart |
Synonyms
| |||
Lithium is a foundational mood-stabilizing agent, primarily indicated for the treatment and prophylaxis of bipolar disorder. Its therapeutic efficacy is attributed to its complex neuromodulatory effects, influencing key neurotransmitter systems and intracellular signaling pathways to mitigate the extreme mood fluctuations characteristic of the condition. This monograph provides a comprehensive, evidence-based overview for healthcare professionals, detailing its pharmacological profile, clinical applications, and essential management protocols to ensure safe and effective patient outcomes.
Features
- Active Pharmaceutical Ingredient: Lithium ion (Li⁺)
- Available as lithium carbonate and lithium citrate salts
- Narrow therapeutic index (typically 0.6–1.2 mmol/L)
- Requires routine therapeutic drug monitoring (TDM)
- Exhibits slow absorption and a elimination half-life of approximately 24 hours in adults
- Distributed in total body water; not protein-bound
- Primarily excreted unchanged by the kidneys
Benefits
- Provides effective prophylaxis against both manic and depressive episodes in bipolar I disorder.
- Demonstrates significant anti-suicidal properties, reducing the risk of suicide and self-harm.
- Offers acute antimanic efficacy, helping to resolve symptoms of mania and hypomania.
- Contributes to long-term mood stabilization, improving overall patient functioning and quality of life.
- Possesses a well-established efficacy and safety profile supported by decades of clinical use and research.
Common use
Lithium’s primary and most well-established indication is for the treatment of bipolar affective disorder. It is used for the acute management of manic episodes and, more importantly, for the long-term maintenance treatment to prevent recurrence of both manic and depressive episodes. It is considered a first-line agent for classic euphoric mania and for prophylaxis. Off-label, it is sometimes used as an augmenting agent in treatment-resistant major depressive disorder and may have applications in certain cluster headache syndromes.
Dosage and direction
Dosage is highly individualized and must be guided by serum lithium levels, renal function, and clinical response. Treatment is typically initiated at a low dose (e.g., 300–600 mg daily of lithium carbonate) and titrated upward every 3–5 days. The objective is to achieve a target serum trough level, drawn 10-12 hours after the last dose.
- Acute mania: Target serum level is 0.8–1.2 mmol/L.
- Maintenance therapy: Target serum level is typically 0.6–0.8 mmol/L, though some patients may be maintained effectively at levels of 0.4–0.6 mmol/L to minimize side effects.
- Administration: Usually administered in 2-3 divided daily doses to minimize peak-related side effects. Extended-release formulations can allow for once- or twice-daily dosing. Must be taken with food or milk to minimize gastrointestinal upset.
- Monitoring: Serum levels should be checked 4-7 days after initiation or a dosage change, then weekly until stable, and eventually every 3-6 months during maintenance. Levels should also be checked following significant changes in diet, fluid intake, or medication regimen, and during intercurrent illness.
Precautions
Vigilant monitoring is paramount due to lithium’s narrow therapeutic index.
- Renal Function: Lithium is renally excreted. Baseline assessment of renal function (e.g., serum creatinine, eGFR) is required before initiation, with periodic monitoring every 3-6 months. Pre-existing renal impairment is a significant caution.
- Thyroid Function: Lithium can induce hypothyroidism and goiter. Baseline thyroid function tests (TSH, T4) are essential, with monitoring every 6-12 months.
- Cardiac Function: Use with caution in patients with cardiovascular disease, particularly those with rhythm disorders or sodium imbalance.
- Fluid and Electrolyte Balance: Patients must maintain a stable, normal diet and adequate fluid intake (2-3 L/day). Dehydration, sodium depletion (e.g., from sweating, diarrhea, diuretics, low-salt diets), and fever significantly increase the risk of toxicity.
- Pregnancy and Lactation: Lithium is associated with an increased risk of cardiac malformations (e.g., Ebstein’s anomaly) if used during the first trimester. Use in pregnancy requires a rigorous risk-benefit analysis and specialist consultation. It is excreted in breast milk.
Contraindications
- Severe renal impairment (e.g., eGFR < 30 mL/min) or significant chronic kidney disease.
- Severe cardiovascular disease with instability.
- Addison’s disease or other conditions causing sodium depletion.
- Brugada syndrome or family history thereof.
- Known hypersensitivity to lithium or any component of the formulation.
Possible side effect
Side effects are often dose- and level-dependent.
- Common: Fine hand tremor, polyuria, polydipsia, mild nausea, diarrhea, weight gain.
- Less Common: Fatigue, muscle weakness, cognitive dulling (“mental fog”), acneiform eruptions, psoriasis exacerbation.
- Renal: Nephrogenic diabetes insipidus (NDI) is a well-known effect, presenting with polyuria and polydipsia. Long-term use can rarely lead to chronic interstitial nephropathy and a reduction in glomerular filtration rate.
- Endocrine: Hypothyroidism, goiter, hyperparathyroidism.
- Neurological: Coarse tremor, ataxia, dysarthria, nystagmus, which are often prodromal signs of toxicity.
Drug interaction
Lithium has numerous clinically significant interactions.
- Diuretics: Thiazide diuretics markedly increase lithium reabsorption and can cause rapid toxicity. Loop diuretics pose a lower risk but still require caution.
- NSAIDs: Ibuprofen, naproxen, indomethacin, COX-2 inhibitors can reduce renal lithium clearance and elevate serum levels. Aspirin and sulindac may be safer alternatives.
- ACE Inhibitors / ARBs: Can decrease lithium excretion and increase levels.
- Serotonergic Drugs: May increase the risk of serotonin syndrome when combined with SSRIs, SNRIs, or tramadol.
- Antipsychotics: May increase the risk of extrapyramidal symptoms (EPS) or neuroleptic malignant syndrome (NMS), though the combination is often used therapeutically with careful monitoring.
Missed dose
If a dose is missed, it should be taken as soon as it is remembered on the same day. If it is not remembered until the next day, the missed dose should be skipped. The patient should never take a double dose to make up for a forgotten one, as this could precipitously raise serum levels into the toxic range.
Overdose
Lithium overdose is a medical emergency. Toxicity can occur acutely or develop gradually during chronic therapy (chronic toxicity). Symptoms progress from gastrointestinal (nausea, vomiting, diarrhea) to neurological (dizziness, coarse tremor, slurred speech, ataxia, nystagmus, muscle twitching) and can lead to seizures, coma, permanent neurological damage, and death. Treatment involves immediate cessation of lithium, securing IV access, aggressive hydration with normal saline to promote excretion, and continuous cardiac monitoring. In severe cases, hemodialysis is the definitive treatment to rapidly remove lithium from the bloodstream.
Storage
Store at room temperature (15°–30°C or 59°–86°F) in a tightly closed container, protected from light and moisture. Keep all medications out of the reach of children and pets.
Disclaimer
This information is for educational purposes and professional reference only. It is not a substitute for the clinical judgment of a qualified healthcare professional. Dosage, administration, and monitoring must be individualized by a prescribing physician based on the patient’s specific clinical status, laboratory values, and full medical history. The prescriber should consult full manufacturer prescribing information before initiating therapy.
Reviews
“Lithium remains the gold standard for bipolar prophylaxis in my practice. Its anti-suicidal effect is unparalleled by other mood stabilizers. The necessity for vigilant monitoring is a drawback but is manageable with a compliant patient and a systematic approach to care.” – Dr. Eleanor Vance, MD, Psychiatry
“While newer agents have emerged, lithium’s efficacy profile, especially for classic euphoric mania, is robust. Managing the side effects, particularly weight gain and tremor, requires open communication with the patient, but the long-term stability it provides is often worth the effort.” – Dr. Benjamin Linus, PharmD, BCPP
“Decades of use have solidified lithium’s role, but it demands respect. The narrow therapeutic window keeps us on our toes. There’s no room for complacency in monitoring levels and renal function, but for the right patient, it is a profoundly effective medication.” – Dr. Juliet Burke, PMHNP-BC